Deksmedetomidin EVER Pharma 100 mikrograma/ml koncentrat za otopinu za infuziju
| Name | Deksmedetomidin EVER Pharma 100 mikrograma/ml koncentrat za otopinu za infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-639074952 |
| Active Substance | deksmedetomidinklorid |
| Composition | jedan ml koncentrata sadrži deksmedetomidinklorid u količini koja odgovara 100 mikrograma deksmedetomidina |
| Pharmaceutical Form | koncentrat za otopinu za infuziju |
| Manufacturer | Ever Pharma Jena GmbH, Jena, Njemačka Ever Pharma Jena GmbH, Jena, Njemačka |
| Marketing Authorisation Holder | EVER Valinject GmbH, Oberburgau 3, Unterach am Attersee, Austrija |
| Marketing Authorisation Date | 16.03.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/143 |
| Registration Number | 381-12-01/70-23-06 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N05CM18 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
Packaging
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o povećanom riziku od smrtnosti u bolesnika u dobi 65 godina i mlađih, vezano uz primjenu lijekova koji sadrže deksmedetomidin na jedinicama intenzivnog liječenja | 15.06.2022 | EVER Valinject GmbH, AS Kalceks, Mylan Ireland Limited, Pliva Hrvatska d.o.o., Orion Corporation, Accord Healthcare S.L.U. |
